MONDAY, May 19, 2025 (HealthDay News) — Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study says. First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of obesity-related cancers, compared withContinue Reading

MONDAY, May 19, 2025 (HealthDay News) — Artificial intelligence (AI) can help detect when a person’s multiple sclerosis (MS) has reached an advanced state, a new study says. A newly developed AI correctly judged with 90% accuracy when a person’s MS had transitioned to a stage where it will progressContinue Reading